Glaucoma News

WASHINGTON — Real-world data show that patients who underwent combined Hydrus microstent implantation and cataract surgery had improved IOP and were on fewer medications at 12 months.

WASHINGTON — Patients with glaucoma who underwent goniotomy and viscodilation with the Streamline surgical system experienced reductions in IOP and medications, according to a study.

WASHINGTON — Patients with pseudoexfoliation glaucoma treated with iStent plus cataract surgery had sustained IOP reduction at 8 years postop, according to a study.

WASHINGTON — Take-home devices can provide IOP monitoring over longer periods of time and give physicians a better understanding of their patients’ glaucoma progression.

WASHINGTON — Telehealth became a necessity during the COVID-19 pandemic and is likely to continue to play an important role in glaucoma care in the future.

WASHINGTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Tom Frinzi, executive chairman of ViaLase, discusses a product in clinical trials for the noninvasive treatment of open-angle glaucoma in a stand-alone procedure.

Phacoemulsification and MIGS rank among the most important innovations in ophthalmology over the past 40 years, according to an email poll of more than 100 readers conducted by Healio/Ocular Surgery News.

A good understanding of gonioscopy is a prerequisite to approach minimally invasive glaucoma surgery, according to a specialist speaking at Real World Ophthalmology.

Automated deep learning analysis of fundus photographs showed high diagnostic accuracy in determining primary open-angle glaucoma, with increased ability to detect glaucoma earlier than human readers.

A 76-year-old woman was referred from optometry for glaucoma evaluation after bilateral optic nerve hemorrhages were found on a routine eye exam. The patient’s ocular history included mild hyperopia and mild dry macular degeneration.